The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European CountriesVerena Hoffmann, Rüdiger Hehlmann, Sonja Burgstaller et al.|Leukemia|2015Cited by 255
Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trialsSrđan Verstovšek, Claire Harrison, Ruben A. Mesa et al.|Blood Advances|2023Cited by 48